Avalo Therapeutics (AVTX) Treasury Shares (2016 - 2026)
Avalo Therapeutics posted quarterly Treasury Shares of $190203.0 for Q1 2026, down 54.86% year-on-year from $421397.0 in Q1 2025, and down 50.86% on a QoQ basis from $387064.0 in Q4 2025.
Avalo Therapeutics (AVTX) has 9 years of Treasury Shares data on file, last reported at $190203.0 in Q1 2026.
- For the quarter ending Q1 2026, Treasury Shares fell 54.86% year-over-year to $190203.0; the trailing twelve-month figure through Mar 2026 stood at $190203.0 (down 54.86% YoY), and the FY2025 full-year result was $387064.0, down 38.77% from the prior year.
- Treasury Shares for Q1 2026 stood at $190203.0, down from $387064.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $632100.0 in Q3 2024 and bottomed at $11250.0 in Q1 2022.
- The 4-year median for Treasury Shares is $421397.0 (2025), against an average of $389613.5.
- The widest annual swing landed in 2022, when Treasury Shares tumbled 92.78%; it then slumped 33.33% in 2025.
- A 4-year view of Treasury Shares shows it stood at $11250.0 in 2022, then soared by 5518.67% to $632100.0 in 2024, then slumped by 38.77% to $387064.0 in 2025, then sank by 50.86% to $190203.0 in 2026.
- The last three Treasury Shares figures came in at $190203.0 (Q1 2026), $387064.0 (Q4 2025), and $421397.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 700,000.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 34.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - | 190,203.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 190,203.00 |
| Mar 31, 2026 | 190,203.00 |
| Dec 31, 2025 | 387,064.00 |
| Dec 31, 2025 | 387,064.00 |
| Sep 30, 2025 | 421,397.00 |
| Sep 30, 2025 | 421,397.00 |
| Jun 30, 2025 | 421,397.00 |
| Jun 30, 2025 | 421,397.00 |
| Mar 31, 2025 | 421,397.00 |
| Mar 31, 2025 | 421,397.00 |
| Dec 31, 2024 | 632,100.00 |
| Dec 31, 2024 | 632,100.00 |
| Sep 30, 2024 | 632,100.00 |
| Sep 30, 2024 | 632,100.00 |
| Mar 31, 2022 | 11,250.00 |
| Mar 31, 2022 | 11,250.00 |
| Dec 31, 2021 | 11,250.00 |
| Dec 31, 2021 | 11,250.00 |
| Sep 30, 2021 | 77,916.00 |
| Sep 30, 2021 | 77,916.00 |
| Jun 30, 2021 | 77,916.00 |
| Jun 30, 2021 | 77,916.00 |
| Mar 31, 2021 | 155,833.00 |
| Mar 31, 2021 | 155,833.00 |
| Dec 31, 2020 | 155,833.00 |
| Dec 31, 2020 | 155,833.00 |
| Sep 30, 2020 | 155,833.00 |
| Sep 30, 2020 | 155,833.00 |
| Jun 30, 2020 | 155,833.00 |
| Jun 30, 2020 | 155,833.00 |
| Mar 31, 2020 | 267,500.00 |
| Mar 31, 2020 | 267,500.00 |
| Dec 31, 2019 | 267,500.00 |
| Dec 31, 2019 | 267,500.00 |
| Sep 30, 2019 | 267,500.00 |
| Sep 30, 2019 | 267,500.00 |
| Jun 30, 2019 | 278,750.00 |
| Jun 30, 2019 | 278,750.00 |
| Mar 31, 2019 | 345,000.00 |
| Mar 31, 2019 | 345,000.00 |
| Dec 31, 2018 | 445,000.00 |
| Dec 31, 2018 | 445,000.00 |
| Sep 30, 2018 | 445,000.00 |
| Sep 30, 2018 | 445,000.00 |
| Jun 30, 2018 | 400,000.00 |
| Jun 30, 2018 | 400,000.00 |
| Mar 31, 2018 | 400,000.00 |
| Mar 31, 2018 | 400,000.00 |
| Jun 30, 2016 | 500,000.00 |
| Jun 30, 2016 | 500,000.00 |